Sign in
CompletedNo phase

Impact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management

Key facts

Who runs it
Centre Hospitalier Universitaire de Nīmes
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
136 people enrolled
Started
8 Feb 2024
Ended
15 Apr 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Echographic hemodynamic algorithm guiding fluid resuscitation
Record updated
16 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Patient in an intensive care unit who develops septic shock on admission or during hospitalization, as defined by SEPSIS-3 criteria
  • Patient or trusted person / legal representative / family member / curator / guardian who has given free and informed consent and has signed the consent form or patient included in an emergency situation
  • Patient affiliated or beneficiary of a health insurance plan
  • Patient at least (≥) 18 years of age

Who cannot take part

  • Cardiac tamponade
  • Dilated cardiomyopathy with LVEF (Left Ventricular Ejection Fraction<40%
  • Refusal of consent
  • Patient under court protection or guardianship
  • Moribund patient with a life expectancy of less than 48 hours
  • Non-echogenic patient
  • Infective endocarditis
  • Intracavitary thrombus
  • Parturient or nursing patient

Other criteria

  • All eligible patients will have a cardiac echocardiogram prior to inclusion for the sole purpose of eliminating special situations that are part of the non-inclusion criteria listed below

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Fluid management is one of the key issues in the initial management of septic shock (SS). Fluid overload and hypovolemia have been associated with increased mortality in several trials. Transthoracic echocardiography (TTE) and lung ultrasound are recommended for haemodynamic assessment in critically ill patients. However, the benefit of hemodynamic optimisation using echography has not been yet evaluated. The purpose of this multicenter, controlled, randomized trial is to assess the impact of an echocardiographic algorithm of hemodynamic optimization on fluid management in septic patients during the first 4 days of therapy.

The 2 groups in the trial

  • Interventional Strategy: STOPFLUID AlgorithmTreatment being tested

    Fluid management is optimised using the specific echographic hemodynamic algorithm ('STOPFLUID') of this study described during the first 4 days of septic shock. Fluid bolus will not be administered in case of increased left ventricle filling pressures; fluid challenge will be performed based on dynamic indices and fluid depletion will be considered on the basis of Lung UltraSound (LUS) assessment.

    Treatment: Echographic hemodynamic algorithm guiding fluid resuscitation

  • Standard StrategyNo study treatment, for comparison

    Fluid management will be handled according to standard care, without using transthoracic echocardiography (TTE) during the first 4 days of septic shock management. Haemodynamic monitoring including pulmonary artery catheter, transpulmonary thermodilution, or any other device will be left at the physician's discretion. TTE will be allowed in the standard group only for excluding cardiac tamponade in case of clinical suspicion (one or more of the following signs: jugular distension, pulsus paradoxus)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management: a Multicentric, Randomized, Controlled, Open Label Pilot-study
Record updated
16 June 2026